CCIA
IART icon

Campbell & Co Investment Adviser’s Integra LifeSciences IART Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,298
Closed -$501K – 1217
2025
Q4 		$501K Buy
+40,298
New +$536K 0.02% 823
2025
Q3 		– Sell
-51,490
Closed -$632K – 1229
2025
Q2 		$632K Buy
+51,490
New +$748K 0.04% 705
2025
Q1 		– Sell
-55,840
Closed -$1.27M – 1159
2024
Q4 		$1.27M Buy
+55,840
New +$1.22M 0.1% 306
2024
Q3 		– Sell
-13,577
Closed -$396K – 1203
2024
Q2 		$396K Sell
13,577
-10,236
-43% -$304K 0.03% 737
2024
Q1 		$844K Sell
23,813
-11,880
-33% -$475K 0.07% 472
2023
Q4 		$1.55M Buy
+35,693
New +$1.4M 0.14% 220
2023
Q3 		– Sell
-10,999
Closed -$452K – 1062
2023
Q2 		$452K Sell
10,999
-21,833
-66% -$1.05M 0.08% 485
2023
Q1 		$1.88M Buy
+32,832
New +$1.85M 0.35% 29
2022
Q4 		– Sell
-15,604
Closed -$661K – 877
2022
Q3 		$661K Buy
+15,604
New +$799K 0.15% 227
2022
Q2 		– Sell
-4,069
Closed -$261K – 786
2022
Q1 		$261K Sell
4,069
-950
-19% -$62.5K 0.07% 525
2021
Q4 		$336K Sell
5,019
-100
-2% -$6.76K 0.12% 316
2021
Q3 		$351K Buy
5,119
+450
+10% +$31.8K 0.11% 321
2021
Q2 		$319K Buy
+4,669
New +$330K 0.13% 303
2019
Q1 		– Sell
-5,767
Closed -$288K – 554
2018
Q4 		$288K Buy
5,767
+132
+2% +$7.24K 0.28% 166
2018
Q3 		$371K Buy
+5,635
New +$350K 0.25% 140
2015
Q4 		– Sell
-10,400
Closed -$310K – 146
2015
Q3 		$310K Buy
+10,400
New +$325K 0.21% 180

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Campbell & Co Investment Adviser's IART Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 40,298 shares — an estimated $501K sold.

Campbell & Co Investment Adviser first reported a position in IART in Q3 2015 and held it in 16 quarters. The position peaked at $1.88M in Q1 2023. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Campbell & Co Investment Adviser reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 40,298 Integra LifeSciences shares in Q1 2026, an estimated $501K.
  • Campbell & Co Investment Adviser first reported a position in Integra LifeSciences in Q3 2015 and held it in 16 quarters.
  • Campbell & Co Investment Adviser's Integra LifeSciences position peaked at $1.88M in Q1 2023.
  • 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.